Nitric Oxide in Asthma Physiopathology
ISRN Allergy · 2011
DOI: 10.5402/2011/832560 ↗Kurz gefasst
Fachartikel in der Zeitschrift ISRN Allergy, 2011. Verfasst von Carla M Prado und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, School of Medicine, University of São Paulo, 04023-900 São Paulo, SP, Brazil ; Departmento de Ciências Biológicas, Universida…. Die Arbeit wurde bisher 87-mal zitiert (Crossref) und nennt 145 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Laboratório de Investigação Médica.
Abstract (Originalsprache)
Asthma is a chronic inflammatory airway disease characterized by allergen-induced airway hyperresponsiveness, airway inflammation, and remodeling. Nitric oxide (NO) derived from constitutive and inducible enzymes affects many aspects of asthma physiopathology. Animal in vivo studies have indicated that inhibition of iNOS may play a central role in the modulation of these features, particularly extracellular matrix remodeling. Additionally, increases in iNOS-derived NO, observed in asthmatic patients, may lead to an increase in peroxynitrite and an imbalance of oxidant and antioxidant pathways. In addition, endogenous nitric oxide produced by constitutive enzymes may protect against the remodeling of the lung. Therefore, nitric oxide donors and/or iNOS inhibitors may have therapeutic potential in asthma treatment and can also be used with corticosteroids to counteract airway remodeling. This paper focuses on the pathophysiological role of nitric oxide, mainly derived from inducible isoforms, in the various pathologic mechanisms of allergic asthma and the importance of nitric oxide and/or arginase inhibitors in asthma treatment.
Autor:innen und Institutionen
- Department of Medicine, School of Medicine, University of São Paulo, 04023-900 São Paulo, SP, Brazil ; Departmento de Ciências Biológicas, Universidade Federal de São Paulo, 04301-012, Diadema, SP, Brazil.
Förderung
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Laboratório de Investigação Médica
Zitieren
APA
Prado, C. M., Martins, M. A., & Tibério, I. F. (2011). Nitric Oxide in Asthma Physiopathology. ISRN Allergy. https://doi.org/10.5402/2011/832560
Vancouver
Prado CM, Martins MA, Tibério IF. Nitric Oxide in Asthma Physiopathology. ISRN Allergy. 2011. doi:10.5402/2011/832560
BibTeX
@article{Prado2011,
author = {Prado, Carla M and Martins, Mílton A and Tibério, Iolanda F L C},
title = {Nitric Oxide in Asthma Physiopathology},
journal = {ISRN Allergy},
year = {2011},
doi = {10.5402/2011/832560}
}
EUVIMED